Mersana Therapeutics Inc (NASDAQ:MRSN)
| 1.26 Delayed Data As of Sep 29 |  -0.01 / -0.79%Today’s Change | 0.80 Today|||52-Week Range 9.62 | -78.50% Year-to-Date |
Latest MRSN News | Press Releases
No recent news for Mersana Therapeutics Inc.
Today’s Trading
| Previous close | 1.27 |
| Today’s open | 1.29 |
| Day’s range | 1.25 - 1.29 |
| Volume | 35,246 |
| Average volume (3 months) | 5,931,993 |
| Market cap | $153.6M |
Data as of 4:00pm ET, 09/29/2023
Growth & Valuation
| Earnings growth (last year) | +9.50% |
| Earnings growth (this year) | +11.49% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +61,716.28% |
| P/E ratio | NM |
| Price/Sales | 20.65 |
| Price/Book | 1.46 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| APLTApplied Therapeutics... | -0.16 | -5.99% |
| MLLCFMolecular Partners A... | 0.00 | 0.00% |
| ADVMAdverum Biotechnolog... | -0.04 | -2.61% |
| ATRAAtara Biotherapeutic... | -0.05 | -3.27% |
Data as of 4:00pm ET, 09/29/2023
Financials
| Next reporting date | November 7, 2023 |
| EPS forecast (this quarter) | -$0.48 |
| Annual revenue (last year) | $26.6M |
| Annual profit (last year) | -$204.2M |
| Net profit margin | -768.26% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
